Safety, Efficacy, Cost: The Trifecta For Increasing Access To CAR-T Therapies

Through the exploration of CAR T-cell therapies, significant opportunities have arisen to extend the applications of these innovative treatments and enhance accessibility, effectively addressing unmet medical requirements. Fundamental to these efforts to make CAR T-cell therapies more broadly available is the need to improve the safety, efficacy, and cost of these treatments.

In this whitepaper, authors review the history and current landscape of CAR T-cell therapy research and development to gain insight from strategies used to increase safety and efficacy, while also lowering cost.